Arkolith/Insider Trading/MLYS/Form 4

Shah Rajeev M.

DirectorMineralys Therapeutics, Inc. (MLYS) · full profile →Form 4 · filed Mar 31, 2026
Net Buying
Open-Market Buys
$8.8M
Open-Market Sells
$0
Net Open-Market Flow
$8.8M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 30, 2026Buy(P)58K$24.16$1.4M5.8M
Mar 27, 2026Buy(P)311K$23.67$7.4M5.8M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001231919-26-000300) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML